NEUE insider files Form 4 showing 16,443-share disposition tied to takeover
Rhea-AI Filing Summary
NeueHealth, Inc. (NEUE) reported a Section 16 Form 4 showing that director Kedrick D. Adkins Jr. recorded a disposition of 16,443 shares of common stock on 10/02/2025 and now holds 0 shares of the public common stock following the transaction. The filing explains that on 10/02/2025 the company completed a merger in which NH Holdings 2025, Inc. acquired the issuer and the issuer became a wholly-owned subsidiary of the acquiring parent.
Under a Rollover Agreement effective at the merger time, the reporting person contributed previously held common stock and Series A and Series B preferred shares into NH Holdings 2025 SPV, L.P. in exchange for corresponding units of the private buyer, resulting in the reported public share disposition. The form is signed by an attorney-in-fact on behalf of the reporting person and documents the change in beneficial ownership tied to the merger and rollover transaction.
Positive
- Insider retained economic interest via exchange into NH Holdings units under the Rollover Agreement
- Transaction documented and reported on Form 4 with attorney-in-fact signature, indicating procedural compliance
Negative
- Public holding reduced to zero for the reporting director after disposition of 16,443 shares on 10/02/2025
- Company became a wholly-owned private subsidiary, which may reduce future public disclosures and liquidity for former public shares
Insights
Director converted public equity to private buyer units during the merger.
The filing shows the issuer merged into a Merger Sub controlled by private funds and became a wholly-owned subsidiary of NH Holdings 2025, Inc. The reporting person exchanged public common and preferred stock for private equity units under a Rollover Agreement, which explains the reported disposition of 16,443 public shares on 10/02/2025.
This reduces the public float while preserving economic exposure via private units; watch for any future disclosures about unit rights or liquidity provisions that affect value conversion timing over the next 12 months.
Form 4 documents a compliant Section 16 disclosure tied to a merger and rollover.
The report clarifies that the transaction was effected under a merger agreement and a rollover agreement, and the Form 4 was signed by an attorney-in-fact, indicating procedural compliance for insider reporting. It records that the reporting person now has no direct public common shares following the effective merger.
Investors should note the change in beneficial ownership status and that future public disclosures may be limited now that the issuer is a private subsidiary; review any follow-up filings or investor communications within the typical merger post-close period.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Common Stock | 16,443 | $0.00 | -- |
Footnotes (1)
- On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. Pursuant to the Rollover Agreement, dated as of August 19, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").
AI-generated analysis. How Rhea-AI works. Not financial advice.
